GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 357E3D
Of the Field

Next Generation Dx Summit 2026

N

ext Generation Dx Summit 2026 is the premier event for decision-makers in advanced diagnostics, bringing together over 400 diagnostics professionals and more than 120 innovation-leading speakers. The event covers a wide scope across clinical and molecular diagnostics, featuring six focused tracks on breakthrough technologies, commercial strategy, and regula…

Visit the official siteRegister
28Voices
5Underwriters
0Exhibitors
0On the bill · sessions
30Companies · in total
§I

The Voices

Programmed at Next, in alphabetical order.
Alexander Baras
MD, PhD, Leon Troper Professorship in Computational Pathology, Associate Professor of Pathology, Urology, and Oncology, Director of Computational Pathology & Informatics · Sidney Kimmel Comprehensive Cancer Center
Anna Bergamaschi
PhD, Vice President Product R&D · ClearNote Health
Brian P. Carey, JD
Partner · Hogan Lovells US LLP
Christine C. Ginocchio, PhD
MT(ASCP), CMO · Qiagen
Clarisa Blattner
Senior Director, Revenue and Payor Optimization · XiFin, Inc.
Courtney H. Lias, PhD
Director, OHT7: Office of in vitro Diagnostic Devices, United States Food and Drug Administration (FDA) · FDA
Elissa Quinn
Medical Director, Cancer Screening & Early Detection · AstraZeneca
Erica Barnell
MD, PhD, Chief Medical and Science Officer · Geneoscopy
Gabriel Bien-Willner
MD, PhD, Medical Director, MolDx · Palmetto GBA LLC
Ipsita G. Smolinski, MBA
Managing Director, Capitol Street; Faculty, Georgetown University · Capitol Street / Georgetown University
Jai Pandey, PhD
Head, Global Device Regulatory IVD/CDx and Digital Health · Sanofi
Jennifer Archer
Senior Director of Market Access · Artera Inc.
Jim Almas
MD, Independent Consultant; Formerly, National Medical Director · Labcorp
Ken Bahk
PhD, CEO · HEI Partners
Lokesh Agrawal
PhD, Chief (Acting), Biorepositories & Biospecimen Research · NIH NCI
Luke Benko
International Business Leader, Digital Pathology · F Hoffmann La Roche AG
Molly Broache
DNP, RN, WHNP-BC, Director, Global Market Access Strategy, Genetic Disease & Reproductive Health · Illumina
Neeraj Adya
PhD, Diagnostic Development Leader, Immunology · Johnson & Johnson
Phillips Kuhl
Founder & Chairman · Cambridge Healthtech Institute
Ramy Arnaout
MD, DPhil, FCAP, FASCP, Associate Director, Clinical Microbiology Laboratories · Beth Israel Deaconess Medical Center
Sheila D. Walcoff, JD
Founding Principal & CEO · Goldbug Strategies LLC
Susan Van Meter
President · American Clinical Laboratory Association

— and 6 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
Abingdon HealthCorporate Sponsor
CytivaCorporate Support Sponsor
MeridianCorporate Sponsor
Meridian BioscienceCorporate Sponsor
TELCORCorporate Support Sponsor
Intermission
Part the Second · For the Buyer

An audience of 30 companies, parsed from the program.

30 companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
0All threespeak · spons · exh
5Sponsoringsponsor only
0Exhibitingexhibitor only
25Speakingspeaker only
02Fig. 02 — The Voices, by Seniority

82% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite621%
  • Founder / Owner27%
  • VP-level414%
  • Director / Head of1139%
  • Other roles518%

Of 28 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 01Abingdon HealthSp·C
  2. 02CytivaSp·C
  3. 03MeridianSp·C
  4. 04Meridian BioscienceSp·C
  5. 05TELCORSp·C
  6. 06Exact Sciences/Screening2V
  7. 07Labcorp2V
  8. 08Tempus AI2V
  9. 09AdvaMedDx1V
  10. 10American Clinical Laboratory Association1V
  11. 11Artera Inc.1V
  12. 12AstraZeneca1V
  13. 13Beth Israel Deaconess Medical Center1V
  14. 14Cambridge Healthtech Institute1V
04Fig. 04 — By Tier
corporate sponsor3
60% of 5
corporate support sponsor2
40% of 5